FDA Adverse Event Malfunction Summary report: N

VITEK® 2 AST-YS08 TEST KIT.

MDR report key: 7125873 · Received December 18, 2017

Report

Report Number
1950204-2017-00461
Event Type
Malfunction
Date Received
December 18, 2017
Report Date
May 18, 2018
Manufacturer
BIOMERIEUX, INC
Product Code
NGZ
PMA / PMN Number
K061945
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A CUSTOMER FROM THE (B)(6) REPORTED TO BIOMÉRIEUX AN OUT OF RANGE LOW (OORL) FLUCONAZOLE (FLU) RESULT FOR A CANDIDA KRUSEI QUALITY CONTROL STRAIN (ATCC 62058), IN ASSOCIATION WITH THE VITEK® 2 AST-YS08 TEST KIT. THE CUSTOMER SUBMITTED THE STRAIN AND CARDS FOR EVALUATION. AN INVESTIGATION WAS PERFORMED. ON VTEK 2 (V7.01), TESTS WERE PERFORMED WITH TWO C. KRUSEI ATCC 6258 STRAINS (INTERNAL REFERENCE STRAIN AND CUSTOMER STRAIN), FROM SDA SUBCULTURED UNDER AEROBIC ATMOSPHERE AS RECOMMENDED. TWO (2) AST-YS08 CARDS LOTS WHICH INCLUDED THE CUSTOMER LOT (2880150203) AND RANDOM LOT (2880297203) WERE TESTED IN DUPLICATE. THE FLU RESULTS WERE MIC = 8 MG/L FOR BOTH LOTS AND WITH BOTH STRAINS TESTED. THE CUSTOMER ISSUE WAS NOT DUPLICATED. THE VITEK 2 AST-YS08 CARD PERFORMED AS INTENDED AND NO FURTHER ACTION IS REQUIRED.

Description of Event or Problem · 1

A CUSTOMER FROM THE (B)(6) REPORTED TO BIOMÉRIEUX AN OUT OF RANGE LOW (OORL) FLUCONAZOLE RESULT FOR A CANDIDA KRUSEI QUALITY CONTROL STRAIN (ATCC 62058), IN ASSOCIATION WITH THE VITEK® 2 AST-YS08 TEST KIT. THE CUSTOMER TESTED THE STRAIN TWICE, BY USING THE AST-YS08 CARD ON TWO DIFFERENT INSTRUMENTS. THE RESULT WAS MIC = 4 FOR BOTH TESTS WITH THE EXPECTED RANGE OF MIC 8 >/= 64. THERE WAS NO PATIENT INVOLVEMENT AS THE EVENT PERTAINED TO A QUALITY CONTROL SAMPLE. A BIOMÉRIEUX INTERNAL INVESTIGATION WILL BE INITIATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
904207 VITEK® 2 AST-YS08 TEST KIT. VITEK® 2 AST-YS08 TEST KIT. NGZ BIOMERIEUX, INC 2880150203

Patients

Seq Age Sex Outcome Treatment
1